Filing metadata

Accession number
0001415889-24-010328
Form type
Form 4
Filer
Theravance Biopharma, Inc.
CIK
CIK 1583107
Filed
Apr 04, 2024
Reporting period
Apr 02, 2024
Description
Insider transaction

Explore SEC Filings Hub